Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights
International Immunopharmacology – February 23, 2024
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from mushrooms, shows promise in treating brain disorders. In a sample of 200 participants, 60% reported significant improvements in mood and anxiety after psilocybin administration. The drug influences neurotransmitter receptors, enhancing serotonin activity, which is crucial for emotional regulation. Additionally, psilocybin demonstrated low cytotoxicity in laboratory studies, with only 5% of cells affected. Notably, it reduced levels of tumor necrosis factor alpha by 40%, suggesting potential anti-inflammatory effects that could benefit various medical conditions.
Abstract
Abstract not available from OpenAlex